Surovatamig is a bispecific antibody engineered to target CD3D, CD3E, and CD19. This antibody features a (H-??4_L-??)_VH-G4(h-CH2-CH3) structure, designed to engage both T cells and B cells for enhanced therapeutic efficacy. Surovatamig is utilized primarily in research focused on the mechanisms of immune response and potential therapeutic applications in immunotherapy. This product is pivotal for studies involving cell signaling and activation in immune cells, making it a valuable tool for investigations into novel cancer treatments and autoimmune disease therapies.
Surovatamig is a bispecific antibody engineered to target CD3D, CD3E, and CD19. This antibody features a (H-??4_L-??)_VH-G4(h-CH2-CH3) structure, designed to engage both T cells and B cells for enhanced therapeutic efficacy. Surovatamig is utilized primarily in research focused on the mechanisms of immune response and potential therapeutic applications in immunotherapy. This product is pivotal for studies involving cell signaling and activation in immune cells, making it a valuable tool for investigations into novel cancer treatments and autoimmune disease therapies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
